REGN

Transfer...
Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Speculative Growth
# of Employee: 4,300 / Fiscal Year End: 2016-12-31 / Stock Type: Large Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | ALXN | VRTX | INCY | BMRN | VVUS |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-03-25Quarter625,740k43,572k11,613k65,443k65,443k112,151,k93.00%10.50%10.50%
2014-06-25Quarter665,700k46,379k10,177k92,735k92,735k113,032,k93.00%13.90%13.90%
2014-09-25Quarter725,788k55,593k9,232k79,720k79,720k117,423,k92.30%11.00%11.00%
2014-12-25Quarter802,329k59,474k6,350k110,176k110,176k114,043,k92.60%13.70%13.70%
2015-03-25Quarter869,612k83,955k6,169k76,021k76,021k114,519,k90.30%8.70%8.70%
2015-06-25Quarter998,617k88,840k2,748k194,643k194,643k115,259,k91.10%19.50%19.50%
2015-09-25Quarter1,137,422k109,083k1,715k210,398k210,398k115,944,k90.40%18.50%18.50%
2015-12-25Quarter1,098,077k110,831k3,609k154,994k154,994k115,488,k89.90%14.10%14.10%
2016-03-25Quarter1,200,849k111,752k0.0165,736k165,736k114,228,k90.70%13.80%13.80%
2016-06-25Quarter1,212,629k69,033k0.0196,218k196,218k116,231,k94.30%16.20%16.20%
2016-12-25Quarter1,226,827k74,681k3,394k253,115k253,115k115,767,k93.90%20.60%20.60%
2017-03-25Quarter1,318,991k84,168k7,501k248,931k248,931k115,106,k93.60%18.90%18.90%
2017-06-25Quarter1,470,116k102,921k5,401k387,744k387,744k116,137,k93.00%26.40%26.40%
2017-09-25Quarter1,500,673k104,232k6,182k388,317k388,317k117,028,k93.10%25.90%25.90%
2017-12-25Quarter1,582,447k105,740k6,035k173,519k173,519k115,834,k93.30%11.00%11.00%
2018-03-25Quarter1,511,485k114,898k6,439k477,980k477,980k114,906,k92.40%31.60%31.60%
2018-06-25Quarter1,608,022k91,661k6,918k551,412k551,412k114,477,k94.30%34.30%34.30%
2018-09-25Quarter1,663,496k110,369k7,494k594,655k594,655k115,088,k93.40%35.70%35.70%
2018-12-25Quarter1,927,797k117,172k7,349k820,353k820,353k114,671,k93.90%42.60%42.60%
2019-03-25Quarter1,711,800k179,200k7,700k461,100k461,100k115,500,k89.50%26.90%26.90%
2019-06-25Quarter1,933,700k152,500k8m193,100k193,100k114,600,k92.10%10.00%10.00%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-03-25Quarter38.97%92.68%-46.88%16.16%16.16%2.11%-2.90%-17.14%-17.14%
2015-06-25Quarter50.01%91.55%-73.00%109.89%109.89%1.97%-2.04%40.29%40.29%
2015-09-25Quarter56.72%96.22%-81.42%163.92%163.92%-1.26%-2.06%68.18%68.18%
2015-12-25Quarter36.86%86.35%-43.17%40.68%40.68%1.27%-2.92%2.92%2.92%
2016-03-25Quarter38.09%33.11%-100.00%118.01%118.01%-0.25%0.44%58.62%58.62%
2016-06-25Quarter21.43%-22.30%-100.00%0.81%0.81%0.84%3.51%-16.92%-16.92%
2016-12-25Quarter7.86%-31.54%97.90%20.30%20.30%-0.15%3.87%11.35%11.35%
2017-03-25Quarter20.12%-24.06%107.84%60.61%60.61%-0.33%4.12%34.04%34.04%
2017-06-25Quarter22.42%-7.90%0.00%133.95%133.95%1.67%2.54%91.30%91.30%
2017-09-25Quarter23.75%50.99%0.00%97.90%97.90%0.69%-1.27%59.88%59.88%
2017-12-25Quarter28.99%41.59%77.81%-31.45%-31.45%0.06%-0.64%-46.60%-46.60%
2018-03-25Quarter14.59%36.51%-14.16%92.01%92.01%-0.17%-1.28%67.20%67.20%
2018-06-25Quarter9.38%-10.94%28.09%42.21%42.21%-1.43%1.40%29.92%29.92%
2018-09-25Quarter10.85%5.89%21.22%53.14%53.14%-1.66%0.32%37.84%37.84%
2018-12-25Quarter21.82%10.81%21.77%372.77%372.77%-1.00%0.64%287.27%287.27%
2019-03-25Quarter13.25%55.96%19.58%-3.53%-3.53%0.52%-3.14%-14.87%-14.87%
2019-06-25Quarter20.25%66.37%15.64%-64.98%-64.98%0.11%-2.33%-70.85%-70.85%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter4,449,245k6,973,466k2,524,221k3,180,188k1,241,495k1,282,726k1.763.390
2017-03-25Quarter4,866,021k7,817,365k2,951,344k3,669,263k1,308,271k1,643,073k1.649.357
2017-06-25Quarter5,520,738k8,106,373k2,585,635k3,860,051k1,029,017k1,556,618k2.135.267
2017-09-25Quarter6,051,593k8,701,215k2,649,622k4,135,742k1,138,628k1,510,994k2.284.275
2017-12-25Quarter6,144,078k8,764,286k2,620,208k4,335,030k1,135,483k1,484,725k2.345.262
2018-03-25Quarter6,567,644k9,372,696k2,805,052k4,544,732k1,265,740k1,539,312k2.341.279
2018-06-25Quarter7,186,426k9,951,980k2,765,554k4,814,917k1,331,190k1,434,364k2.599.276
2018-09-25Quarter7,868,300k10,805,613k2,937,313k5,719,583k1,417,230k1,520,083k2.679.248
2018-12-25Quarter8,757,300k11,734,500k2,977,200k6,447,600k1,442,800k1,534,400k2.941.224
2019-03-25Quarter9,444,700k12,854,800k3,410,100k6,928,600k1,511,400k1,898,700k2.770.218

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter38.09%25.68%3.80%36.31%-8.54%15.75%33.01%-32.82%
2018-03-25Quarter34.97%19.90%-4.96%23.86%-3.25%-6.32%41.96%-21.85%
2018-06-25Quarter30.17%22.77%6.96%24.74%29.37%-7.85%21.73%3.37%
2018-09-25Quarter30.02%24.19%10.86%38.30%24.47%0.60%17.29%-9.82%
2018-12-25Quarter42.53%33.89%13.62%48.73%27.06%3.35%25.42%-14.50%
2019-03-25Quarter43.81%37.15%21.57%52.45%19.41%23.35%18.33%-21.86%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note